BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24904105)

  • 1. ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia.
    Padron E; Yoder S; Kunigal S; Mesa T; Teer JK; Al Ali N; Sekeres MA; Painter JS; Zhang L; Lancet J; Maciejewski JP; Epling-Burnette PK; Sotomayor E; Komrokji RS; List AF
    Blood; 2014 Jun; 123(23):3675-7. PubMed ID: 24904105
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
    Boultwood J; Perry J; Pellagatti A; Fernandez-Mercado M; Fernandez-Santamaria C; Calasanz MJ; Larrayoz MJ; Garcia-Delgado M; Giagounidis A; Malcovati L; Della Porta MG; Jädersten M; Killick S; Hellström-Lindberg E; Cazzola M; Wainscoat JS
    Leukemia; 2010 May; 24(5):1062-5. PubMed ID: 20182461
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
    Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7.
    Wall M; Rayeroux KC; MacKinnon RN; Zordan A; Campbell LJ
    Haematologica; 2012 Dec; 97(12):1933-6. PubMed ID: 22875624
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts.
    Gelsi-Boyer V; Cervera N; Bertucci F; Brecqueville M; Finetti P; Murati A; Arnoulet C; Mozziconacci MJ; Mills KI; Cross NC; Vey N; Birnbaum D
    Haematologica; 2013 Apr; 98(4):576-83. PubMed ID: 23065512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutated
    Valencia-Martinez A; Sanna A; Masala E; Contini E; Brogi A; Gozzini A; Santini V
    Haematologica; 2017 Sep; 102(9):e332-e335. PubMed ID: 28522578
    [No Abstract]   [Full Text] [Related]  

  • 7. PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia.
    Bataller A; Chien KS; Sasaki K; Montalban-Bravo G; Kanagal-Shamanna R; Urrutia S; Almanza-Huante E; Gener-Ricos G; Ravandi F; Jabbour E; Kadia T; Borthakur G; Garcia-Manero G
    Leuk Res; 2023 Apr; 127():107044. PubMed ID: 36801700
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis and clinical significance of ETV6 rearrangement in myelodysplastic syndromes patients].
    Ding BT; Guo NJ; Sun JZ; Gao HM; Wang YS; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):804-7. PubMed ID: 18476590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focus on myeloproliferative diseases and myelodysplastic syndromes.
    Van Etten RA; Shannon KM
    Cancer Cell; 2004 Dec; 6(6):547-52. PubMed ID: 15607959
    [No Abstract]   [Full Text] [Related]  

  • 12. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic role of ETV6 fusion gene in leukemic transformation of myelodysplastic syndrome refractory anemia with excess blasts-1 with a new, rare translocation t(11;19)(q24.3;q13.12) and insertion ins(6;12)(p22.3p13).
    Jarošová M; Rohoň P; Živná J; Peková S; Nedomová R; Holzerová M; Mičková P; Reptová S; Papajík T; Indrák K
    Leuk Lymphoma; 2014 Apr; 55(4):950-3. PubMed ID: 23772667
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Cull AH; Mahendru D; Snetsinger B; Good D; Tyryshkin K; Chesney A; Ghorab Z; Reis M; Buckstein R; Wells RA; Rauh MJ
    Leuk Res; 2018 Feb; 65():5-13. PubMed ID: 29227812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13).
    Janssen H; Wlodarska I; Mecucci C; Hagemeijer A; Vandenberghe P; Marynen P; Cools J
    Haematologica; 2006 Jul; 91(7):949-51. PubMed ID: 16757412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts.
    Mauvieux L; Helias C; Perrusson N; Lioure B; Sorel N; Brizard F; Lessard M
    Leukemia; 2004 Aug; 18(8):1436-8. PubMed ID: 15175627
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.
    Shou LH; Cao D; Dong XH; Fang Q; Wu Y; Zhang Y; Fei JP; Xu BL
    PLoS One; 2017; 12(2):e0171608. PubMed ID: 28158286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline ETV6 mutations and predisposition to hematological malignancies.
    Feurstein S; Godley LA
    Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
    Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
    Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.